AIBLE Therapeutics
PrivateLast Round
Early Funding
Nov 1, 2023
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AIBLE Therapeutics is a digital health company that develops AI-powered mobile applications for the screening, diagnosis, and management of neuropsychiatric disorders such as dementia.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Mental Health, Medical Devices, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIBLE Therapeutics Comparables
Compare AIBLE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seven Point One | 90% | |
| Voinosis | 88% | |
| Silvia Health Inc. | 87% |
AIBLE Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 1, 2023 | ||||
| VC Round | Dec 1, 2022 | ||||
| Seed | Oct 1, 2021 |
AIBLE Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bigbang Angels, Inc. | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 92% MoM.
- Apr 7, 2026
Monthly visitors increased 836% MoM to 2.6K.
AIBLE Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AIBLE Therapeutics's valuation, stock price, and market status.
Is AIBLE Therapeutics a public or private company?
AIBLE Therapeutics is a private company.
What is the current stock price of AIBLE Therapeutics?
AIBLE Therapeutics is a private company, so its shares have no public market price. Caplight tracks AIBLE Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AIBLE Therapeutics worth (valuation)?
Valuation information for AIBLE Therapeutics is not publicly available.
Can I buy AIBLE Therapeutics stock?
AIBLE Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AIBLE Therapeutics's last funding round?
AIBLE Therapeutics's most recent funding round was Early Funding on November 1, 2023.
Who are the main investors in AIBLE Therapeutics?
Key investors in AIBLE Therapeutics include Bigbang Angels, Inc..
Will AIBLE Therapeutics IPO soon?
No public IPO plans have been announced for AIBLE Therapeutics.
How can I track AIBLE Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in AIBLE Therapeutics's shares on secondary markets.